YOLFTbeta
30

Beijing Scitop Bio Tech Co Ltd

300858 · SHE · Healthcare / Biotechnology

13.31CNY-0.35 (-2.56%)

Price History

Full chart

Market Stats

Previous Close13.66
Open13.42
Day Range13.27 – 13.66
52-Week Range13.02 – 26.89
Volume2.00M
Market Cap3.98B
P/E (TTM)50.40
Forward P/E0.00
EPS0.30
Dividend Yield0.66%
Beta0.24
50-Day Avg14.55
200-Day Avg16.63

About

Beijing Scitop Bio-tech Co., Ltd. engages in the research, development, production, and sale of probiotic, postbiotics, and microecological preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women's health, slimming and fat reduction, kidney and liver protection, blood sugar regulation, allergy relief, blood pressure regulation, and mother-infant transmission, as well as exercise, bone, heart, and skin health applications. The company also offers microecological preparations and related application technologies for ruminants, monogastric livestock and poultry animals, aquatic animals, and pets. In addition, it develops and promotes microbial agents, such as microbial fertilizers, bio-organic fertilizers, organic material decomposition agents, etc. for vegetable, fruit, edible fungus, forage grass, and crop planting. Beijing Scitop Bio-tech Co., Ltd. was founded in 2003 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Xiaojun Liu
  • Employees413
  • HeadquartersNo. 1-2, No. 31, Niuhe Road, Beijing, China, 101407, China
  • Websitehttps://www.scitop.cn

Leadership

  • Mr. Xiaojun LiuGM & Director · b. 1981
  • Mr. Ziying YuAccounting Supervisor, Deputy GM & CFO · b. 1964
  • Mr. Xiangqian QiaoDeputy GM & Director · b. 1974
  • Mr. Weichen BaoDeputy General Manager · b. 1984
  • Mr. Lingyu ZhangBoard Secretary & Deputy GM · b. 1990
  • Mr. Jianjun ZhangDeputy General Manager · b. 1983
  • Ms. Qimuge SuduDeputy General Manager · b. 1983

Financials

Income Statement

Currency: CNY2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue185.41M260.62M283.76M317.90M308.10M339.16M364.62M369.17M299.24M302.79M365.92M
Growth (%)-+40.56%+8.88%+12.03%-3.08%+10.08%+7.51%+1.25%-18.94%+1.19%+20.85%
Cost of Revenue111.06M144.51M151.06M160.82M150.63M175.27M181.17M177.29M135.91M126.41M177.46M
Gross Profit74.35M116.11M132.69M157.08M157.46M163.88M183.45M191.88M163.33M176.38M188.46M
Gross Margin40.10%44.55%46.76%49.41%51.11%48.32%50.31%51.98%54.58%58.25%51.50%
Operating Expense27.83M95.98M44.86M50.02M46.75M46.17M58.75M64.30M60.73M66.92M104.06M
Operating Income46.52M20.12M87.84M107.06M110.72M117.71M124.70M127.58M102.60M109.46M84.40M
Operating Margin25.09%7.72%30.95%33.68%35.94%34.71%34.20%34.56%34.29%36.15%23.07%
EBITDA48.07M26.05M91.79M111.46M116.10M123.06M139.53M142.75M121.07M133.66M137.69M
EBITDA Margin25.93%10.00%32.35%35.06%37.68%36.28%38.27%38.67%40.46%44.14%37.63%
Net Income35.02M11.54M71.35M91.92M93.28M96.58M109.54M109.89M93.48M94.36M94.52M
Net Income Margin18.89%4.43%25.14%28.91%30.28%28.48%30.04%29.77%31.24%31.16%25.83%
R&D6.04M9.39M13.35M16.59M14.75M17.57M27.15M22.09M34.19M36.33M35.71M
R&D as % of Total Revenue3.26%3.60%4.70%5.22%4.79%5.18%7.45%5.98%11.43%12.00%9.76%
Interest Expense-0280.87K191.54K381.32K37.47K475.58K455.81K548.24K282.35K144.43K
Interest Expense % of Total Revenue-0.00%0.10%0.06%0.12%0.01%0.13%0.12%0.18%0.09%0.04%

Balance Sheet

Currency: CNY2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets184.55M266.26M337.39M373.74M465.97M999.25M1.04B1.79B1.81B1.92B2.02B
Total Liabilities131.89M71.69M56.30M71.91M66.14M66.66M73.33M93.99M77.10M126.03M176.08M
Total Equity52.67M193.11M281.09M301.83M399.83M932.59M967.40M1.70B1.73B1.79B1.84B
Cash47.59M30.85M121.63M55.11M100.16M202.29M481.82M875.36M191.60M108.64M99.70M
Total Debt70.11M13.00M-8.30M-8.34M8.61M7.70M9.90M3.23M-
Net Debt22.52M-17.85M-121.63M-46.81M-100.16M-193.95M-473.21M-867.66M-179.94M-105.41M-

Cash Flow

Currency: CNY2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.69M32.73M84.00M89.55M98.27M66.67M110.27M148.46M107.27M142.11M123.44M
Investing Cash Flow-12.57M-94.67M17.68M-94.79M-44.56M-404.25M252.57M-373.04M-739.71M-184.33M-
Financing Cash Flow52.64M45.20M-10.90M-61.65M-8.36M439.71M-83.31M618.12M-54.32M-40.73M-
Capital Expenditure5.66M21.06M47.25M95.99M46.25M21.28M67.57M84.18M178.47M211.50M296.12M
Free Cash Flow-2.97M11.67M36.75M-6.44M52.02M45.39M42.70M64.28M-71.21M-69.38M-172.68M
Dividends Paid1.61M32.99M20.41M69.65M356.24K82.52M82.52M74.46M52.70M39.52M39.52M
FCF to OCF-110.68%35.66%43.75%-7.19%52.94%68.08%38.72%43.30%-66.38%-48.82%-139.89%
Dividend Paid to FCF-54.14%282.65%55.54%-1081.94%0.68%181.79%193.27%115.85%-74.01%-56.97%-22.89%

Earnings

Report DateSep 30, 2020Dec 31, 2020Apr 22, 2021Aug 27, 2021Oct 29, 2021Dec 31, 2021Apr 26, 2022Aug 24, 2022Oct 27, 2022Apr 18, 2023Aug 1, 2023Oct 24, 2023Apr 24, 2024Aug 21, 2024Oct 29, 2024Apr 22, 2025Aug 20, 2025Oct 22, 2025Apr 23, 2026Aug 24, 2026
EPS Estimate--------------------
EPS Actual0.150.110.260.160.270.110.160.140.280.110.080.120.080.090.100.090.080.130.060.04
Surprise--------------------
Timing------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market----

Key Statistics & Ratios

Market Cap3.98B
Enterprise Value3.31B
Trailing P/E50.40
Forward P/E0.00
Price / Sales10.71
Price / Book2.22
EPS0.30
Book Value6.80
Revenue (TTM)372.08M
Gross Profit (TTM)187.59M
EBITDA84.95M
Profit Margin21.07%
Operating Margin4.16%
Return on Equity4.38%
Return on Assets1.51%
Shares Outstanding263.50M
Shares Float142.88M
Beta0.24
Dividend Yield0.66%
Dividend Rate0.10
Payout Ratio43.74%

Dividends

20261×
0.10Jul 10, 2026
20251×
0.15Jul 16, 2025
20241×
0.15Jul 3, 2024
20231×
0.30Jun 30, 2023
20221×
0.33Jun 29, 2022
20211×
0.37Jul 2, 2021

Stock Splits

  • Jun 30, 20231.5:1
  • Jul 2, 20211.8:1